Radiology Trainees 95.9 Percent Right
Radiology trainees incorrectly interpreted pediatric neuroimaging scans 4.1 percent of the time, with a tiny fraction - 0.17 percent - of all readings erring in ways “major and potentially life-threatening,” according to a new study published in the American Journal of Neuroradiology.
Radiology trainees incorrectly interpreted pediatric neuroimaging scans 4.1 percent of the time, with a tiny fraction - 0.17 percent - of all readings erring in ways “major and potentially life-threatening,” according to a new study published in the American Journal of Neuroradiology.
Lead author James Leach, MD, and colleagues at the Cincinnati Children’s Hospital Medical Center considered 3,496 trainee-dictated examination reports. They found 143 errors, amounting to a discrepancy rate of 4.1 percent. Most discrepancies - 131, or 92 percent - occurred on CT examinations.
Most of these were minor, with no impact on clinical management (97, or 68 percent), or resulted simply in clinical reassessment or imaging follow-up (43, or 30 percent). Thirty-seven were overcalls. But six were major and potentially life-threatening.
The most common misinterpretations were related to fractures (28) and intracerebral hemorrhage (23). CT examinations of the face, orbits, and neck had the highest discrepancy rate (9.4 percent). Third- and fourth-year residents had a larger discrepancy rate than fellows. The authors said such detailed analysis of the types of misinterpretations can be used to inform proactive trainee education.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
